August 2, 2024: Blood Clots, DVT, Pulmonary Embolisms Possibly Linked to GLP-1 Drugs A data analysis published in the Endocrine Journal has medical professionals taking a new look at how semaglutide drugs might cause a specific type of blood clot
November 2023 : Eli Lilly received US FDA approval for ZEPBOUND, an obesity treatment that activates GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors
Tuy nhin kh nng sn xut collagen ca c th s gim dn theo tui tc
J Sci Food Agric 102(8):30653077 Gulati K, Verma P, Rai N, Ray A (2021) Role of nutraceuticals in respiratory and allied diseases
Animal studies reveal it reduces weight gain, enhances fat breakdown, and maintains energy levels without impacting insulin sensitivity or causing genotoxicity
5-Amino-1MQ (Capsules) NNMT Inhibitor CAS: 42464-96-0 Formula: C 10 H 12 N 2 M.W.: 160.2192 g/mol Purity: 99%+ HPLC Verified Ref No.: 5-A-0050TA For Research Use Only (RUO) Not for human or veterinary use